← Leaderboards
Yi-Guang Chen
Jackson Laboratory
$9,291,015
Attributed
$14,473,574
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.5M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,473,574 · 10
By mechanism
R01$7,136,271 · 2
DP3$4,294,866 · 1
R21$2,095,151 · 5
R00$736,362 · 1
K99$210,924 · 1
Top collaborators
- William M Ridgway10 shared
- John Driver2 shared
- Aron M Geurts1 shared
Most similar at Jackson Laboratory
Same institution · by research overlap
- Tatyana V. Golovkina$20,197,921
- Petko M Petkov$8,477,854
- Sheng Li$6,545,752
- David V. Serreze$20,047,270
- Michael Lee Stitzel$8,196,494
Others in their field
Top investigators on “Inbred Nod Mice”
- Roland Michael Tisch · Univ Of North Carolina Chapel Hill$13,153,998
- Emil R Unanue · Washington University$12,716,410
- David V. Serreze · Jackson Laboratory$12,356,238
- Brian T Fife · University Of Minnesota$9,856,983
- Luc Teyton · Scripps Research Institute, The$9,810,908
- Kevan C Herold · Columbia University Health Sciences$9,462,499
Research focus
Inbred Nod MiceInsulin-Dependent Diabetes MellitusStructure Of Beta Cell Of IsletCellsT-LymphocyteRegulatory T-LymphocyteCd4 Positive T LymphocytesImmuneDiabetogenicMediatingMouse ModelGenesAutoimmune ProcessAutoimmune DiseasesPathway InteractionsPathogenicityCd8-Positive T-LymphocytesNon ObeseDiabeticIn VitroProductionProteinsCandidate Disease GeneLink
Grant awards (31)
Mechanistic and therapeutic role of the CD137-CD137L axis in Type 1 Diabetes$636,595
R01 · FY2025 · DK · contact PI
PTPN22 controls the interrelationship of IL-21+ and FOXP3+ CD4 T cells in T1D$190,000
R21 · FY2025 · AI · contact PI
Mechanistic and therapeutic role of the CD137-CD137L axis in Type 1 Diabetes$611,130
R01 · FY2024 · DK · contact PI
PTPN22 controls the interrelationship of IL-21+ and FOXP3+ CD4 T cells in T1D$228,000
R21 · FY2024 · AI · contact PI
Mechanistic and therapeutic role of the CD137-CD137L axis in Type 1 Diabetes$634,906
R01 · FY2023 · DK · contact PI
Mechanistic and therapeutic role of the CD137-CD137L axis in Type 1 Diabetes$633,723
R01 · FY2022 · DK · contact PI
Shaping diabetogenic T cells by IL-27 in type 1 diabetes$358,783
R01 · FY2022 · DK · contact PI
Mechanistic and therapeutic role of the CD137-CD137L axis in Type 1 Diabetes$642,329
R01 · FY2021 · DK · contact PI
Shaping diabetogenic T cells by IL-27 in type 1 diabetes$365,289
R01 · FY2021 · DK · contact PI
Genetic analysis of islet-infiltrating IL-21-expressing CD4 T cells in type 1 diabetes$190,000
R21 · FY2021 · AI · contact PI
Mechanistic and Therapeutic Role of the CD137-CD137L Axis in Type 1 Diabetes$482,209
R01 · FY2020 · DK · contact PI
Shaping diabetogenic T cells by IL-27 in type 1 diabetes$371,608
R01 · FY2020 · DK · contact PI
Genetic analysis of islet-infiltrating IL-21-expressing CD4 T cells in type 1 diabetes$228,000
R21 · FY2020 · AI · contact PI
Mechanistic and Therapeutic Role of the CD137-CD137L Axis in Type 1 Diabetes$487,598
R01 · FY2019 · DK · contact PI
Shaping diabetogenic T cells by IL-27 in type 1 diabetes$390,740
R01 · FY2019 · DK · contact PI
Genetic control of autoimmune diabetes inducing cytotoxic T cells$184,365
R21 · FY2019 · AI
Mechanistic and Therapeutic Role of the CD137-CD137L Axis in Type 1 Diabetes$492,860
R01 · FY2018 · DK · contact PI
Genetic control of autoimmune diabetes inducing cytotoxic T cells$236,036
R21 · FY2018 · AI
Mechanistic and Therapeutic Role of the CD137-CD137L Axis in Type 1 Diabetes$497,993
R01 · FY2017 · DK · contact PI
A new genetic approach to identify the Idd9.3 type 1 diabetes susceptibility gene$190,000
R21 · FY2017 · AI · contact PI
Mechanistic and Therapeutic Role of the CD137-CD137L Axis in Type 1 Diabetes$530,508
R01 · FY2016 · DK · contact PI
A new genetic approach to identify the Idd9.3 type 1 diabetes susceptibility gene$228,000
R21 · FY2016 · AI · contact PI
Genetic engineering of the Idd3 type 1 diabetes locus$191,250
R21 · FY2015 · AI · contact PI
Genetic engineering of the Idd3 type 1 diabetes locus$229,500
R21 · FY2014 · AI · contact PI
Discovery and Functional Studies of Genes for T1D GWAS Susceptibility Loci$4,294,866
DP3 · FY2012 · DK
Role of the iNKT-Dendritic Cell Axis in Type 1 Diabetes in NOD Mice$240,851
R00 · FY2012 · DK · contact PI
Role of the iNKT-Dendritic Cell Axis in Type 1 Diabetes in NOD Mice$246,511
R00 · FY2011 · DK · contact PI
Role of the iNKT-Dendritic Cell Axis in Type 1 Diabetes in NOD Mice$249,000
R00 · FY2010 · DK · contact PI
Role of the iNKT-Dendritic Cell Axis in Type 1 Diabetes in NOD Mice$54,000
K99 · FY2009 · DK · contact PI
Role of the iNKT-Dendritic Cell Axis in Type 1 Diabetes in NOD Mice$78,462
K99 · FY2008 · DK · contact PI
Role of the iNKT-Dendritic Cell Axis in Type 1 Diabetes in NOD Mice$78,462
K99 · FY2007 · DK · contact PI